| Value | ₹2,763 Cr |
|---|
BSE filing, NSE: LALPATHLAB. Summary written from the filing by ALFA Finder's alert engine.
Dr. Lal Pathlabs Ltd: key numbers
- Share price
- ₹1,907.20
- Market cap
- ₹32,012 Cr
- Revenue (annual)
- ₹2,763 Cr
- Net profit (annual)
- ₹504.8 Cr
- P/E (TTM)
- 59.1×Sector 52.3×
- Promoter holding
- 52.93%-0.26% QoQ
- FII holding
- 18.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Lal Pathlabs Ltd
All →Dr. Lal Pathlabs Board Meeting Date
Dr. Lal PathLabs updated its 4 November 2026 board meeting notice to add a possible second interim dividend. The meeting will also approve unaudited quarterly results.
Dr. Lal Pathlabs Acquisition Worth ₹30.3 Cr
Dr. Lal PathLabs subscribed to WOS PUPL equity to fund PUPL's buyout of remaining 30% in CentraPath Labs for ₹30.3 Crore. CentraPath becomes a wholly owned subsidiary.
- Value
- ₹30.30 Cr
Dr. Lal Pathlabs Other Announcement
Dr. Lal PathLabs submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, received from its RTA.
Dr. Lal Pathlabs Legal & Regulatory
Dr. Lal PathLabs disclosed an ITAT tax appeal against a favorable order for Rs.32.66 Crore ESOP expense relief (AY 2022-23). The company expects no material financial impact.
- Value
- ₹32.66 Cr
Dr. Lal Pathlabs Other Announcement
Dr. Lal PathLabs reported PIT disclosures for trades by designated persons and its Employee Welfare Trust, totaling approximately ₹0.83 Crore. These involved ESOP allotments and market sales.
- Value
- ₹0.09 Cr
Dr. Lal Pathlabs Acquisition Worth ₹38 Cr
Dr. Lal Path Labs' subsidiary completed the acquisition of an 80% stake in Sunshine Healthcare Limited, Ghana, for Rs.38.00 Crore. The target is now a subsidiary.
- Value
- ₹38.00 Cr
Other annual report announcements
All →Dalmia Bharat Sugar and Industries Annual Report
Dalmia Bharat Sugar released its Integrated Annual Report for FY2025-26. It covers the Tanzania entry, the demerger and the Baghauli integration.
Milestone Furniture Annual Report
Milestone Furniture published its 12th Annual Report for FY2025-26 with AGM notice for 21 November 2026. Agenda covers accounts, auditor appointment, capital increase and director appointments.
CMX Holdings Annual Report
Riwind Green Energy (formerly CMX Holdings) submitted its 35th Annual Report for FY 2025-26, acknowledging a delay in filing. The AGM was held on 30 September 2026.
Aesthetik Engineers Annual Report
Aesthetik Engineers filed its Integrated Annual Report for FY2025-26 with the 18th AGM notice. The AGM will be held on November 28, 2026 via video conferencing.
Evexia Lifecare Annual Report
Evexia Lifecare filed its FY 2025-26 Annual Report ahead of its 35th AGM on 30 September 2026. It contains financial and governance disclosures, with no new transaction.
Ardee Industries Annual Report
Ardee Industries filed its FY 2025-26 Annual Report and 33rd AGM notice under Regulation 34(1). The submission includes audited financials, governance and MD&A reports.